FDA gives Merck ‘real-time’ OK for Keytruda, offering a peek at the latest extension of the...

[cafead]

via The federal agency has stamped a full approval — following last year’s conditional OK — on Merck’s mega-blockbuster Keytruda for frontline use in a chemo combo for fighting non-squamous non-small cell lung cancer.

article source